Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial.
暂无分享,去创建一个
H. Yoshikawa | T. Onda | T. Yasugi | T. Hirakawa | T. Kamura | N. Katsumata | R. Tsunematsu | Kaichiro Yamamoto | M. Mushika | T. Fujii | T. Saito